Skip to main content

Market Overview

699
Articles
183K
Views

Vandana Singh

Benzinga Staff Writer

April 09, 2021 7:04 AM
Affimed NV (NASDAQ: AFMD) has announced initial clinical data from an investigator-sponsored study evaluating cord blood-derived ...
April 09, 2021 7:00 AM
KemPharm Inc (NASDAQ: KMPH) has amended the collaboration and license agreement with Gurnet Point Capital (GPC), a priv ...
April 09, 2021 6:56 AM
Greenwich LifeSciences Inc (NASDAQ: GLSI) has announced the abstract results of the final 5-year immune response data of the Phas ...
April 09, 2021 6:37 AM
Celcuity Inc (NASDAQ: CELC) has entered into a global licensing agreement with Pfizer Inc (NYSE: PFE), granting Ce ...
April 09, 2021 6:30 AM
Provention Bio Inc (NASDAQ: PRVB) revealed it had received a notification on April 2 from the FDA stating that the agency has ide ...
April 08, 2021 2:59 PM
The U.S. government will allot around 85% less Johnson & Johnson's (NYSE: JNJ) COVID-19 vaccines to states next week, data fro ...
April 08, 2021 1:38 PM
Abbott Laboratories (NYSE: ABT) won European approval for the latest generation of its TriClip system, a transcatheter-based repa ...
April 08, 2021 12:14 PM
The British government and health experts in the country have come forward to defend the COVID-19 vaccine developed by AstraZeneca plc’s&n ...
April 08, 2021 11:22 AM
ImmunoPrecise Antibodies Ltd's (NASDAQ: IPA) subsidiary Talem Therapeutics LLC has advanced developing a candidate  ...
April 08, 2021 11:12 AM
Biogen Inc (NASDAQ: BIIB) and Bio-Thera Solutions Ltd have entered into a commercialization and license agreement to develop, man ...
April 08, 2021 10:59 AM
ImmunityBio Inc (NASDAQ: IBRX) has reported initial data from the Phase 1 study evaluating its hAd5 COVID-19 vaccine candidate in ...
April 08, 2021 10:43 AM
Ocuphire Pharma Inc (NASDAQ: OCUP) has screened the first patient in Phase 2 ZETA-1 trial evaluating APX3330 in non-pro ...
April 08, 2021 10:40 AM
AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) has announced an investigator-initiated study to assess the perioperative use of Dsuvia ...
April 08, 2021 10:36 AM
Hologic Inc (NASDAQ: HOLX) has agreed to acquire Mobidiag Oy, a privately held, Europe-based provider of molecular diagnostic tes ...
April 08, 2021 9:07 AM
ElectroCore Inc (NASDAQ: ECOR) has announced top-line results from the SAVIOR-1 study evaluating non-invasive vagus nerve stimula ...
April 08, 2021 9:04 AM
Royalty Pharma plc (NASDAQ: RPRX) has acquired Dicerna Pharmaceuticals Inc's (NASDAQ: DRNA) royalty interest in Oxl ...
April 08, 2021 8:29 AM
BeiGene Ltd (NASDAQ: BGNE) has announced data from Phase 2 trial evaluating Brukinsa (zanubrutinib) in hospitalized COV ...
April 08, 2021 8:26 AM
Merck & Co Inc (NYSE: MRK) has announced interim data from Phase 3 KEYNOTE-564 trial evaluating Keytruda as a potential adjuv ...
April 08, 2021 8:02 AM
Bristol-Myers Squibb Co (NYSE: BMY) has announced positive topline results from Phase 3 CheckMate 648 trial evaluating ...
April 08, 2021 7:41 AM
Eli Lilly And Co (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) have reported results from the COV-BARRIER ...
April 08, 2021 7:38 AM
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) has presented additional efficacy data from the AURA-LV and AURORA 1 trials of Lupkyni ...
April 08, 2021 7:20 AM
Global Blood Therapeutics Inc (NASDAQ: GBT) has announced The Lancet Haematology has published the complete analysis of 72-week data&n ...
April 08, 2021 6:52 AM
Results from a sub-analysis of patients with diabetes mellitus from Phase 3 SONICS study evaluating Strongbridge Biopharma plc's&n ...
April 08, 2021 6:47 AM
The FDA has granted regular approval to Gilead Sciences Inc's (NASDAQ: GILD) Trodelvy (sacituzumab govitecan) for an agg ...
April 07, 2021 1:31 PM
Better Therapeutics Inc, a company developing prescription-only smartphone-based treatments for Type 2 diabetes and high blood pressure, has agr ...
April 07, 2021 12:28 PM
The National Institutes of Health (NIH) has begun a mid-stage study to determine the risk of allergic reactions shortly after receiving COV ...
April 07, 2021 12:23 PM
LumiraDx, a UK-based provider of point-of-care diagnostics, including COVID-19 tests, has withdrawn its initial public offering plans. It had planned ...
April 07, 2021 11:16 AM
The European Medicines Agency (EMA), after an in-depth analysis, has concluded that unusual blood clots should be listed as a “very ra ...
April 07, 2021 10:46 AM
AIM ImmunoTech Inc (NYSE: AIM) has completed the dosing of Cohort 1 in Phase 1 study on the safety of Ampligen as an intranasal t ...
April 07, 2021 10:42 AM
AbbVie Inc (NYSE: ABBV) has submitted marketing applications to the FDA and European Medicines Agency (EMA) seeking approval for ...